HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib

Lu, ZW; Wang, ZX; Tu, ZG; Liu, HQ

Liu, HQ (通讯作者)，Jiangsu Univ, Sch Pharm, Zhenjiang, Peoples R China.;Tu, ZG (通讯作者)，Jiangsu Univ, Sch Life Sci, Zhenjiang, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2022; 13 ():

Abstract

Mantle cell lymphoma (MCL) is a highly aggressive and heterogeneous B-cell lymphoma. Though Bruton's tyrosine kinase (BTK) inhibitor ibrutinib has sho......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索